Table 2: Persistence or clearance of specific high-risk (HR) HPV infection after follow-up.

HPV typesClearance
(%)
Persistence
(%)
Total

1612 (35.3)22 (64.7)34
183 (50)3 (50)6
312 (100)0 (0)2
330 (0)2 (100)2
451 (100)0 (0)1
531 (50)1 (50)2
581 (100)0 (0)1
590 (0)1 (100)1
660 (0)1 (100)1
671 (50)1 (50)2
690 (0)1 (100)1
830 (0)2 (100)2
HR-HPV21 (38.2)34 (61.8)55